FDA Center for Drug Evaluation & Research Director Janet Woodcock admits that the agency has a lot to learn from patients about drug development and regulatory policy.
“We understand that people with chronic diseases are experts in that disease, as far as the symptoms and the impact on quality of life, and what might be acceptable trade-offs...